Home  |  Contact

UniProtKB/Swiss-Prot P20823: Variant p.His143Tyr

Hepatocyte nuclear factor 1-alpha
Gene: HNF1A
Variant information

Variant position:  143
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Histidine (H) to Tyrosine (Y) at position 143 (H143Y, p.His143Tyr).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and polar (H) to large size and aromatic (Y)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In MODY3.
Any additional useful information about the variant.

Sequence information

Variant position:  143
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  631
The length of the canonical sequence.

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.





Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

Chain 1 – 631 Hepatocyte nuclear factor 1-alpha
Domain 87 – 182 POU-specific atypical
Region 143 – 149 Interaction with DNA
Alternative sequence 120 – 631 Missing. In isoform 8.
Mutagenesis 127 – 127 N -> W. Abolishes transcription activation.
Mutagenesis 132 – 132 E -> K. Abolishes transcription activation.
Helix 141 – 149

Literature citations

Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation.
Hansen T.; Eiberg H.; Rouard M.; Vaxillaire M.; Moeller A.M.; Rasmussen S.K.; Fridberg M.; Urhammer S.A.; Holst J.J.; Almind K.; Echwald S.M.; Hansen L.; Bell G.I.; Pedersen O.;
Diabetes 46:726-730(1997)
Cited for: VARIANTS MODY3 ASN-128; TYR-143 AND LEU-447;

Allelic drop-out in exon 2 of the hepatocyte nuclear factor-1alpha gene hinders the identification of mutations in three families with maturity-onset diabetes of the young.
Ellard S.; Bulman M.P.; Frayling T.M.; Allen L.I.S.; Dronsfield M.J.; Tack C.J.; Hattersley A.T.;
Diabetes 48:921-923(1999)
Cited for: VARIANTS MODY3 GLU-117 AND TYR-143;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.